Barclays
BHVN icon

Barclays’s Biohaven BHVN Stock Holding History

Barclays’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Buy
132,959
+7,137
+6% +$76.8K ﹤0.01% 2344
2026
Q1 		$1.06M Sell
125,822
-195,024
-61% -$2.13M ﹤0.01% 2720
2025
Q4 		$3.62M Sell
320,846
-25,998
-7% -$322K ﹤0.01% 2472
2025
Q3 		$5.21M Sell
346,844
-319
-0.1% -$4.64K ﹤0.01% 2165
2025
Q2 		$4.9M Buy
347,163
+183,545
+112% +$3.27M ﹤0.01% 2155
2025
Q1 		$3.93M Sell
163,618
-229,109
-58% -$8.08M ﹤0.01% 2101
2024
Q4 		$14.7M Buy
392,727
+124,650
+46% +$5.82M ﹤0.01% 1294
2024
Q3 		$13.4M Buy
268,077
+125,189
+88% +$4.87M ﹤0.01% 1287
2024
Q2 		$4.96M Buy
142,888
+56,954
+66% +$2.25M ﹤0.01% 1544
2024
Q1 		$4.7M Sell
85,934
-140,969
-62% -$6.98M ﹤0.01% 1900
2023
Q4 		$9.71M Buy
226,903
+50,990
+29% +$1.59M ﹤0.01% 1542
2023
Q3 		$4.58M Buy
175,913
+63,943
+57% +$1.33M ﹤0.01% 1370
2023
Q2 		$2.68M Sell
111,970
-30,817
-22% -$530K ﹤0.01% 1692
2023
Q1 		$1.95M Sell
142,787
-53,281
-27% -$848K ﹤0.01% 2216
2022
Q4 		$2.72M Buy
+196,068
New +$2.77M ﹤0.01% 2034

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's BHVN Position: Q2 2026 in Review

Barclays increased its Biohaven (BHVN) stake by 5.7% in Q2 2026, buying an estimated $76.8K and bringing the position to 132,959 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #2344.

Barclays first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $14.7M in Q4 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Barclays held 132,959 shares of Biohaven worth $1.98M as of Q2 2026.
  • Barclays bought 7,137 Biohaven shares in Q2 2026, an estimated $76.8K.
  • Biohaven made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2344 holding.
  • Barclays first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Barclays's Biohaven position peaked at $14.7M in Q4 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.